Wen Hsin Koo

1.2k total citations
29 papers, 896 citations indexed

About

Wen Hsin Koo is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wen Hsin Koo has authored 29 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wen Hsin Koo's work include Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Chemotherapy-related skin toxicity (4 papers). Wen Hsin Koo is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Chemotherapy-related skin toxicity (4 papers). Wen Hsin Koo collaborates with scholars based in Singapore, Japan and Taiwan. Wen Hsin Koo's co-authors include London Lucien Ooi, Wan Yee Lau, Benjamin O. Anderson, Pierce K. H. Chow, Eric Van Cutsem, Wan Cheng Chow, Kōichi Tanaka, Khin Maung Win, Li‐Tzong Chen and Harjit Singh and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and The Lancet Oncology.

In The Last Decade

Wen Hsin Koo

29 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Hsin Koo Singapore 12 322 275 217 169 153 29 896
Justin Parekh United States 17 145 0.5× 173 0.6× 351 1.6× 229 1.4× 427 2.8× 36 965
Ai‐Xuan L. Holterman United States 12 250 0.8× 87 0.3× 162 0.7× 177 1.0× 282 1.8× 18 867
Jianguo Shao China 16 249 0.8× 86 0.3× 268 1.2× 282 1.7× 96 0.6× 43 720
Jonathan Hundley United States 16 207 0.6× 116 0.4× 208 1.0× 103 0.6× 373 2.4× 22 803
Andrea A. Florio United States 12 237 0.7× 248 0.9× 231 1.1× 316 1.9× 358 2.3× 22 1.0k
Driss Chaoui France 16 318 1.0× 478 1.7× 52 0.2× 177 1.0× 78 0.5× 29 1.1k
Michael Davies United Kingdom 13 87 0.3× 434 1.6× 82 0.4× 108 0.6× 478 3.1× 30 997
Kshama Jaiswal United States 13 145 0.5× 162 0.6× 120 0.6× 106 0.6× 395 2.6× 28 741
Robert Barnes United States 12 256 0.8× 289 1.1× 87 0.4× 111 0.7× 242 1.6× 27 1.1k
Tomáš Rohan Czechia 14 163 0.5× 282 1.0× 29 0.1× 113 0.7× 211 1.4× 45 687

Countries citing papers authored by Wen Hsin Koo

Since Specialization
Citations

This map shows the geographic impact of Wen Hsin Koo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Hsin Koo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Hsin Koo more than expected).

Fields of papers citing papers by Wen Hsin Koo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Hsin Koo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Hsin Koo. The network helps show where Wen Hsin Koo may publish in the future.

Co-authorship network of co-authors of Wen Hsin Koo

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Hsin Koo. A scholar is included among the top collaborators of Wen Hsin Koo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Hsin Koo. Wen Hsin Koo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choo, Su Pin, David Tai, Iain Bee Huat Tan, et al.. (2019). What is the value of third‐line chemotherapy in advanced gastroesophageal cancer? A 5‐year retrospective analysis at a single center. Asia-Pacific Journal of Clinical Oncology. 16(1). 23–27. 2 indexed citations
2.
Yap, Yoon Sim, Nicholas Syn, Wen Yee Chay, et al.. (2017). Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine–Induced Hand-Foot Syndrome. JAMA Oncology. 3(11). 1538–1538. 67 indexed citations
3.
Tan, Kok Hian, et al.. (2015). Academic Medicine Education Institute (AM∙EI): Transforming the Educational Culture of Health Professionals. Annals of the Academy of Medicine Singapore. 44(5). 172–177. 4 indexed citations
4.
Yap, Yoon Sim, Nan Soon Wong, Soo Kien Lo, et al.. (2015). Predictors of hand-foot syndrome (HFS) in randomised double-blind, placebo-controlled trial of pyridoxine for prevention of capecitabine induced HFS.. Journal of Clinical Oncology. 33(15_suppl). 9596–9596. 2 indexed citations
5.
Koo, Wen Hsin, et al.. (2012). Improvements in End-of-Life Care with a Protocol-based Pathway for Cancer Patients Dying in a Singapore Hospital. Annals of the Academy of Medicine Singapore. 41(11). 483–493. 11 indexed citations
6.
Farid, Mohamad, Min Hoe Chew, Whee Sze Ong, et al.. (2012). Localized gastrointestinal stromal tumor of the rectum: An uncommon primary site with prominent disease and treatment-related morbidities. Molecular and Clinical Oncology. 1(1). 190–194. 15 indexed citations
7.
Farid, Mohamad, Balram Chowbay, Sze Huey Tan, et al.. (2012). Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 70(1). 141–150. 3 indexed citations
8.
Toh, Han Chong, Who-Whong Wang, Whay Kuang Chia, et al.. (2009). Clinical Benefit of Allogeneic Melanoma Cell Lysate–Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients. Clinical Cancer Research. 15(24). 7726–7736. 54 indexed citations
9.
Poon, Dennis, et al.. (2009). An exploratory analysis of comprehensive geriatric assessment results and overall survival in 233 consecutive elderly cancer patients. Journal of Clinical Oncology. 27(15_suppl). 9504–9504. 4 indexed citations
10.
Poon, Donald, Benjamin O. Anderson, Li‐Tzong Chen, et al.. (2009). Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. The Lancet Oncology. 10(11). 1111–1118. 324 indexed citations
11.
Chia, Whay Kuang, Simon Yew Kuang Ong, Han Chong Toh, et al.. (2008). Phase II Trial of Gemcitabine in Combination with Cisplatin in Inoperable or Advanced Hepatocellular Carcinoma. Annals of the Academy of Medicine Singapore. 37(7). 554–558. 10 indexed citations
12.
Quek, R., Wan‐Teck Lim, Kian Fong Foo, Wen Hsin Koo, & Han Chong Toh. (2006). Capcitabine and oxaliplatin (XELOX) in the treatment of advanced gastric cancer. Journal of Clinical Oncology. 24(18_suppl). 14089–14089. 1 indexed citations
13.
Lim, Wan‐Teck, et al.. (2003). CPT-11 and Cisplatin in the Treatment of Advanced Gastric Cancer in Asians. Journal of Chemotherapy. 15(4). 400–405. 12 indexed citations
14.
Cheung, YB, Gordon Ng, Wen Hsin Koo, et al.. (2003). Measuring Quality of Life in Chinese Cancer Patients: A New Version of the Functional Living Index for Cancer (Chinese). Annals of the Academy of Medicine Singapore. 32(3). 376–380. 11 indexed citations
15.
Koo, Wen Hsin, et al.. (2001). Hypodermoclysis or subcutaneous infusion revisited.. PubMed. 42(11). 526–9. 21 indexed citations
16.
Nyam, Denis, et al.. (1999). Transpelvic rectus abdominis flap for perineal reconstruction following abdominal perineal resection with en bloc partial cystectomy and prostatectomy for locally advanced rectal cancer.. PubMed. 40(10). 654–5. 4 indexed citations
17.
Koo, Wen Hsin, et al.. (1997). Case report: Delayed radiation pneumonitis induced by chemotherapy. Clinical Radiology. 52(9). 720–723. 1 indexed citations
18.
Au, Elizabeth H., et al.. (1996). A Phase II Trial of Etoposide, Leucovorin and 5-Fluorouracil (ELF) in Patients with Advanced Gastric Cancer. Journal of Chemotherapy. 8(4). 300–303. 3 indexed citations
19.
Koo, Wen Hsin, et al.. (1996). Role of maintenance oral dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy. Annals of Oncology. 7(1). 71–74. 34 indexed citations
20.
Koo, Wen Hsin, et al.. (1989). A study of the P blood group system in the Singaporean population.. PubMed. 30(4). 372–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justin Parekh Breakdown of academic impact, for papers by Ai‐Xuan L. Holterman Breakdown of academic impact, for papers by Jianguo Shao Breakdown of academic impact, for papers by Jonathan Hundley Breakdown of academic impact, for papers by Andrea A. Florio Breakdown of academic impact, for papers by Driss Chaoui Breakdown of academic impact, for papers by Michael Davies Breakdown of academic impact, for papers by Kshama Jaiswal Breakdown of academic impact, for papers by Robert Barnes Breakdown of academic impact, for papers by Tomáš Rohan
Rankless by CCL
2026